- Видео 34
- Просмотров 3 412
Ori Biotech
Добавлен 30 мар 2021
Ori Biotech is an innovator in Cell and Gene Therapy manufacturing, delivering scalable solutions to address the critical needs of therapeutics developers.
Boro Dropulić: Simplifying CAR-T workflows will break down barriers to patient access
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Boro Dropulić, CEO of Vector Biomed and Executive Director at Caring Cross.
Boro shares his vision of how decentralized manufacturing, low-cost vector production, and open-source workflows can make cell and gene therapies more accessible worldwide. They also discuss the role of digital technologies, partnerships, and innovative processes in overcoming industry bottlenecks, driving down costs, and expanding this access.
Learn more about Boro: www.linkedin.com/in/boro-dropuli%C4%87-6759154/
Boro shares his vision of how decentralized manufacturing, low-cost vector production, and open-source workflows can make cell and gene therapies more accessible worldwide. They also discuss the role of digital technologies, partnerships, and innovative processes in overcoming industry bottlenecks, driving down costs, and expanding this access.
Learn more about Boro: www.linkedin.com/in/boro-dropuli%C4%87-6759154/
Просмотров: 1
Видео
Michael Krajewski: How does the Theory of Constraints apply to CGT manufacturing?
Просмотров 8121 день назад
In this episode of the Ori Spotlight Podcast, Jason Foster is joined by Michael Krajewski, Director at Stand Back and an expert in engineering and scaling operations. Michael, with his background in aeronautics, brings a unique perspective on the Theory of Constraints and its role in CGT manufacturing processes. Michael and Jason dive into the complex dynamics of bottlenecks and discuss how und...
Carl Schoellhammer: viability is the crucial third pillar in CGT
Просмотров 584 месяца назад
In this episode, Jason C. Foster welcomes Carl Schoellhammer, Principal & Advanced Therapies Practice Lead at DeciBio, to discuss the importance of considering viability alongside safety and efficacy in cell and gene therapies (CGTs). Schoellhammer highlights the need for scalable and decentralized manufacturing approaches to ensure the commercial viability of these advanced therapies, as well ...
Anshul Mangal: Unlocking scale, automation, digitalization and standardization in CGT
Просмотров 875 месяцев назад
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Anshul Mangal, President at Project Farma, to discuss the hurdles to scalable CGT development, the importance of early strategic planning, and the role of digitalization in improving efficiency and reducing costs. Together they also highlight the potential of distributed manufacturing and the evolution of regulatory standard...
Omkar Kawalekar: technology will unlock scalability and patient access
Просмотров 1055 месяцев назад
In this episode, Omkar Kawalekar of Deloitte's NextGenTherapies practice joins Ori CEO Jason C. Foster, to explore the significance of technology and strategic collaborations in overcoming manufacturing challenges and developing advanced therapies at scale. Their conversation covers key industry hurdles like supply chain optimization and the strategic planning necessary for bringing innovative ...
Joe DePinto: bridging growth and accessibility within CGTs
Просмотров 1476 месяцев назад
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Joe DePinto, head of Cell and Gene Advanced Therapies at McKesson, to discuss challenges and innovations in cell and gene therapy manufacturing and supply chains. Together they also highlight the importance of collaborative partnerships and digital innovations to enhance access and streamline processes within the CGT sector....
Matthew Hewitt: scalability is a collective problem
Просмотров 767 месяцев назад
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Matthew Hewitt, Vice President and Technical Officer of Cell and Gene Therapy and Biologics at Charles River Laboratories, to discuss why industry collaboration is needed to experience the true impact of advanced therapies and develop them at a commercial scale. Together they also highlight the role of technology in closing,...
Adam Siebert & Jeff Holder: early investment in manufacturing is critical for CGT accessibility
Просмотров 1348 месяцев назад
In this episode of the Ori Spotlight Podcast, Jason C. Foster hosts Jeff Holder and Adam Siebert from LEK Consulting, offering an in-depth exploration of the evolving cell and gene therapy (CGT) industry. LEK Consulting, a global leader in strategic advisory, aims to address the critical challenges of scalability and commercial viability within the CGT sector. Jeff and Adam, with their extensiv...
Jim Faulkner: unaffordable therapy success is worse than failure...
Просмотров 1278 месяцев назад
In this episode of Ori Spotlight Podcast, we welcome Jim Faulkner, PhD, Independent Consultant at JDB BioConsulting and former SVP of Product Delivery at Autolus. Jim brings a wealth of experience from his remarkable career in biopharmaceutical development and his journey in the industry is marked by significant contributions, particularly in pioneering cell therapy at GSK. The episode offers a...
Sanjay Srivastava: are CGTs developing into a commercial dead-end?
Просмотров 889 месяцев назад
In this episode of the Ori Spotlight Podcast, we're joined by Sanjay Srivastava, Managing Director of Accenture's Cell and Gene Therapy Practice. With his extensive background in consulting and a deep understanding of the biotechnology sector, Sanjay offers unique insights into the rapidly evolving world of cell and gene therapies. Sanjay and Jason C. Foster delve into the critical challenges f...
Jason C. Foster interviews Bruce Thompson at ARM's Meeting on the Mesa
Просмотров 13310 месяцев назад
Jason C. Foster interviews Bruce Thompson at ARM's Meeting on the Mesa
Jason C. Foster interviews Matthew Hewitt at ARM's Meeting on the Mesa
Просмотров 11610 месяцев назад
Jason C. Foster interviews Matthew Hewitt at ARM's Meeting on the Mesa
Jason C. Foster interviews Jason Bock at ARM's Meeting on the Mesa
Просмотров 8910 месяцев назад
Jason C. Foster interviews Jason Bock at ARM's Meeting on the Mesa
2023 Data Release: Jason C. Foster at the Cell & Gene Meeting on the Mesa
Просмотров 75311 месяцев назад
2023 Data Release: Jason C. Foster at the Cell & Gene Meeting on the Mesa
Tim Hunt: leading CGT with education and community
Просмотров 53Год назад
Tim Hunt: leading CGT with education and community
Vered Caplan: why yesterday’s thinking is not going to solve today’s problems
Просмотров 187Год назад
Vered Caplan: why yesterday’s thinking is not going to solve today’s problems
Daniel Gibson: improving patient access to cell therapies
Просмотров 60Год назад
Daniel Gibson: improving patient access to cell therapies
Dr Betty Woo: Why it's important to take calculated risks early in your career
Просмотров 47Год назад
Dr Betty Woo: Why it's important to take calculated risks early in your career
Jason Bock - Cell Manufacturing Therapy Center (CTMC)
Просмотров 66Год назад
Jason Bock - Cell Manufacturing Therapy Center (CTMC)
John Lee: “Cellicon Valley” accelerates development and manufacturing of innovative CGTs
Просмотров 104Год назад
John Lee: “Cellicon Valley” accelerates development and manufacturing of innovative CGTs
The Whitehead and Jones Families - Patient Advocates
Просмотров 38Год назад
The Whitehead and Jones Families - Patient Advocates
Amy Kappen: connecting CAR-T families with The Best Day Ever Foundation
Просмотров 109Год назад
Amy Kappen: connecting CAR-T families with The Best Day Ever Foundation
Isabelle Rivière - Memorial Sloan-Kettering Cancer Center (MSKCC)
Просмотров 46Год назад
Isabelle Rivière - Memorial Sloan-Kettering Cancer Center (MSKCC)
William Raimes, Head of Process Development
Просмотров 72Год назад
William Raimes, Head of Process Development
Amazing!